Prevalence of essential urological diseases among rural population
- Authors: Arustamov DL1, Nurullaev RВ1
-
Affiliations:
- Issue: No 6 (2004)
- Pages: 3-6
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/276195
- ID: 276195
Cite item
Full Text
Abstract
A retrospective one-stage epidemiological trial was made to investigate
prevalence of urinary infections (UI), urolithiasis (UL) and
benign prostatic hyperplasia (BPH) among rural population, to reveal
latent or initial stages of these diseases and to specify preventive policy.
2330 rural one-year-olds and older children (n = 345, 14.8%)
were covered by a screening examination forbacteriuria, leukocyturia,
crystaluria and symptoms of the lower urinary tract caused by benign
prostatic hyperplasia (BPH). UI, UL, BPH were detected in 7.0%
(70:1000), 17.9% (179:1000) and 17.3% (173:1000), respectively. UI
and UL ran a latent course. The former needed an antibacterial preventive
therapy, the latter - prophylaxis of primary lithogenesis. Alpha-adrenoblockers
were indicated for BPH patients. All the necessary
therapeutic and prophylactic measures can be realized outpatiently
by general practitioners
prevalence of urinary infections (UI), urolithiasis (UL) and
benign prostatic hyperplasia (BPH) among rural population, to reveal
latent or initial stages of these diseases and to specify preventive policy.
2330 rural one-year-olds and older children (n = 345, 14.8%)
were covered by a screening examination forbacteriuria, leukocyturia,
crystaluria and symptoms of the lower urinary tract caused by benign
prostatic hyperplasia (BPH). UI, UL, BPH were detected in 7.0%
(70:1000), 17.9% (179:1000) and 17.3% (173:1000), respectively. UI
and UL ran a latent course. The former needed an antibacterial preventive
therapy, the latter - prophylaxis of primary lithogenesis. Alpha-adrenoblockers
were indicated for BPH patients. All the necessary
therapeutic and prophylactic measures can be realized outpatiently
by general practitioners
References
- Stamm W. E., Norrby S. Я. Urinary tract infections: Disease panorama and challenges. J. Infect. Dis. 2001; 183: 1-9.
- Лопаткин Н. А., Мартов А. Г. Состояние и перспективы развития урологической помощи в Российской Федерации. В кн.: Российский съезд урологов, 10-й: Материалы. М.; 2002. 5-26.
- Лопаткин Н. А., Деревянко И. И. Неосложненные и осложненные инфекции мочеполовых путей. Принципы антибактериальной терапии. Рус. мед. журн. 1997; 24: 1579- 1589.
- Лоран О. Б. Эпидемиологические аспекты инфекции мочевыводящих путей. Аптека 1999; 3-4: 8-9.
- Matthew Е., Gorbach S. L. Practice guide lines: urinary tract infections. IDCP 1995; 4: 241-254.
- Everaert K., VanLaeke E., Dekuyper P. et al. Impact of urinary tract infection and detrusor pressure on renal tubular function in patients with vesicoureteral reflux. Eur.Urol. 2001; 39: 337- 342.
- Nikkila M. Т., Pasternack A. Prevalence of urolithiasis in a Finnish district. An epidemiologic study of adults in Tampere.Scad. J. Urol. Nephrol. 1998; (4): 293-297.
- Hesse A.,Braendle E., Wilbert D. et al. Prevalence and incidence of urolithiasis in Germany an epidemiologic update. In: Ш"1 European symposium on urolithiasis (Istanbul, June 11 - 14 2003). Istanbul; 2003. 174.
- Арустамов Д. Л., Юлдашев Ф. Ю., Клепов Ю. Ю. Распространенность мочекаменной болезни в Узбекистане по данным эпидемиологических исследований. Мед. журн. Узбекистана 1997; 3: 26-29.
- Tiselius H. G. Epidemiology and medical management of stone disease. Br. J. Urol. 2003; 91(8): 758-767.
- Baumann J. M., Affolter В., Caprez C.I. et al. Calcium oxalate aggregation in whole urine, new aspects of calcium stone formation and metaphylaxis. Eur. Urol. 2003; 4: 421-425.
- Radikaite G., Blazis J., Firantiene R. Urinary excretion of calcium, oxalate, phosphate, uric acid, magnesium, citrate in children with preurolithiasis and effect of magnesium citrate. In: 9"' European Symposium on urolithiasis (Rotterdam, sept. 13-15 2001). Rotterdam; 2001. 45-46.
- Пасечник Д. Г., Коган М. И., Тарек М. К вопросу об эпидемиологии доброкачественной гиперплазии предстательной железы. В кн.: Российский съезд урологов, 10-й: Материалы. М.; 2002. 156-157.
- Винаров А. З., Асламазов Э. Г. Гиперплазия предстательной железы. Современное лечение. В кн.: Российский съезд урологов, 10-й: Материалы. М.; 2002. 33-42.
- Аполихин О. И., Сивков А. В. Административные и экономические аспекты оказания медицинской помощи больным ДГПЖ. В кн.: Российский съезд урологов, 10-й: Материалы. М.; 2002. 45-51.
- Schaeffer A. J. Infection of the urinary tract. Urology 1998; 15: 533-614.
- Fang-Liu G. Changes in the prevalence of benign prostatic hyperplasia in China. 1997; 110: 163-166.
Supplementary files
